Vaccinations in Poor Countries

Deal provides vaccines to poor countries at lower prices, By Andrew Pollack, March 23, 2010, New York Times: “Pfizer and GlaxoSmithKline will supply hundreds of millions of doses of their pneumonia vaccines to the world’s poorest countries at heavily discounted prices under a novel agreement announced Tuesday. The deal was announced by the GAVI Alliance, a nonprofit organization, which estimated the program could save 900,000 lives by 2015. The vaccines, Pfizer’s Prevnar 13 and GlaxoSmithKline’s Synflorix, prevent pneumococcal disease, which includes pneumonia and meningitis. Pneumococcal disease kills 1.6 million people a year throughout the world, including 800,000 children before their fifth birthday, according to GAVI…”